SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

NOXOPHARM LIMITED (NOX)

Listed on ASX

SHARE PRICES

Former (or subsequent) names

 

Shareholder links

Our website ranking of NOX: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Registry Services Level 5 126 Phillip Street Sydney NSW 2000

Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
Fax :
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000NOX9
Address: Suite 3 Level 4 828 Pacific Highway GORDON NSW 2072
Tel:  +61 2 91442223 Fax: +61 2 91999600

Date first listed: 09/08/2016
Company Secretary: David Franks
Sector: Pharmaceuticals & Biotechnology Industry Group: 
Activities: Pharmaceuticals and Biotechnology

The securities of Noxopharm Limited will be reinstated to quotation immediately, following the release of an announcement by the Company.

24/08/2017

The company announces the placement of 16,666,667 fully paid ordinary shares to sophisticated and institutional investors at a price of $0.33 per share, raising a total of A$5,500,000 (before costs). Noxopharm has raised the funds to enable it to accelerate the clinical development of its front-line drug, NOX66, currently undergoing clinical trialing.

24/08/2017

The securities of Noxopharm Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company.

23/08/2017

listed entity carried for record purposes only

09/08/2016

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    24/07/2020Fred Bart-3,056,318$0.344$1,051,068
    10/09/2019Christopher Cox53,263$0.358$19,063
    06/09/2019Christopher Cox11,737$0.362$4,250
    13/02/2019Christopher Cox65,553$0.416$27,282
    19/12/2016Christopher Cox152,653$0.538$82,127

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Fred BartNon Exec Chairman08/05/2020
    Peter MarksDeputy Chairman, Non Exec Director09/08/2016
    Graham KellyCEO27/10/2015
    Boris PatkinNon Exec Director26/03/2020
    Christopher CoxDirector09/08/2016

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Ian DixonNon Exec Director09/08/201631/08/2020
    Greg van WykCEO23/04/201928/10/2019
    Beata NiechodaNon Exec Director16/07/201916/10/2019
    John MooreNon Exec Director21/11/201816/07/2019

    Date of first appointment, title may have changed.